ArticleScientific reports2025

BT-11 targets the LANCL2 pathway to attenuate cognitive deficits and hippocampal pathology in Alzheimer's transgenic rats.

Emily M Birnbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.